Skip to main
VYNE
VYNE logo

Vyne Therapeutics (VYNE)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Vyne Therapeutics (VYNE) Stock

About Vyne Therapeutics (VYNE)

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercializes solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company was founded in October 2011 and is headquartered in Bridgewater, NJ.
Market cap$27.5M
Today's volume608.94K
Revenue (TTM)$605K
Avg. daily volume483.1K
EBITDA (TTM)-$45.44M
Open$1.65
Price / earnings ratio-1.67x
Today's range$1.64 - $1.93
Debt / equity0.14x
52 week range$0.85 - $4.3
5 year debt / equity18.17x
Beta (LTM)0.96x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio4.47x
Ex-dividend date
Next earningsAug 13, 2025
Dividend payable date

Vyne Therapeutics Stock Rating

What analysts recommend for VYNE stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for VYNE stock is $27.5M

The current P/E ratio for VYNE stock is -1.67

The 52-week high for VYNE stock is $4.30. The current VYNE stock price $undefined is 100.00% below its 52-week high

The 52-week low for VYNE stock is $0.85. The current VYNE stock price $undefined has increased 100.00% from its 52-week low

No, the VYNE stock does not pay dividends to its shareholders

The target price for VYNE stock is $7.17 based on the average of what a group of analyst think VYNE stock could be worth at a future date. This is not a prediction by Public.com

How to buy VYNE stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in VYNE stock

    Navigate to the Explore page. Then, type VYNE into the search bar. When you see VYNE stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased VYNE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Vyne Therapeutics Stock Earnings

The value each VYNE share was expected to gain vs. the value that each VYNE share actually gained.

Vyne Therapeutics (VYNE) reported Q1 2025 earnings per share (EPS) of -$0.20, beating estimates of -$0.29 by 31.03%. In the same quarter last year, Vyne Therapeutics's earnings per share (EPS) was -$0.15. Vyne Therapeutics is expected to release next earnings on 08/13/2025, with an earnings per share (EPS) estimate of $0.

Buy Vyne Therapeutics (VYNE) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.